(Q43591184)

English

Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2.

scientific article published on 25 August 2009

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2. (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

vector-borne disease

0 references

0 references

Trypanosoma cruzi

0 references

1 reference

based on heuristic

inferred from title

Mamoru Hasegawa

6

object named as

Mamoru Hasegawa

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

author name string

Xuefeng Duan

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Yoshikazu Yonemitsu

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Bin Chou

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Kumi Yoshida

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sakura Tanaka

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Kohhei Tetsutani

7

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Hidekazu Ishida

8

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Kunisuke Himeno

9

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Hajime Hisaeda

10

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

language of work or name

0 references

publication date

25 August 2009

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

44

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

6154-6159

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Specific treatment of Chagas disease: current status and new developments

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.026

7 January 2021

Trypanosoma cruzi: susceptibility to chemotherapy with benznidazole of clones isolated from the highly resistant Colombian strain

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.026

7 January 2021

Trypanosoma cruzi: partial prevention of the natural infection of guinea pigs with a killed parasite vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.026

7 January 2021

Protective immunity against Trypanosoma cruzi provided by oral immunization with Phytomonas serpens: role of nitric oxide.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.026

7 January 2021

Immunization with a plasmid DNA containing the gene of trans-sialidase reduces Trypanosoma cruzi infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.026

7 January 2021

DNA sequences encoding CD4+ and CD8+ T-cell epitopes are important for efficient protective immunity induced by DNA vaccination with a Trypanosoma cruzi gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.026

7 January 2021

Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.026

7 January 2021

Coadministration of an interleukin-12 gene and a Trypanosoma cruzi gene improves vaccine efficacy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.026

7 January 2021

Genetic immunization with LYT1 or a pool of trans-sialidase genes protects mice from lethal Trypanosoma cruzi infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.026

7 January 2021

Immunotherapy of Trypanosoma cruzi infection with DNA vaccines in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.026

7 January 2021

Critical contribution of immunoproteasomes in the induction of protective immunity against Trypanosoma cruzi in mice vaccinated with a plasmid encoding a CTL epitope fused to green fluorescence protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.026

7 January 2021

Cruzipain induces both mucosal and systemic protection against Trypanosoma cruzi in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.026

7 January 2021

Immunization with cDNA expressed by amastigotes of Trypanosoma cruzi elicits protective immune response against experimental infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.026

7 January 2021

Protective Immunity Against Trypanosoma cruzi Infection in a Highly Susceptible Mouse Strain After Vaccination with Genes Encoding the Amastigote Surface Protein-2 and Trans-Sialidase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.026

7 January 2021

Immunization with an engineered mutant trans-sialidase highly protects mice from experimental Trypanosoma cruzi infection: a vaccine candidate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.026

7 January 2021

Prime-boost immunization with cruzipain co-administered with MALP-2 triggers a protective immune response able to decrease parasite burden and tissue injury in an experimental Trypanosoma cruzi infection model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.026

7 January 2021

Safety of recombinant fowlpox strain FP9 and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.026

7 January 2021

Immunogenicity of the candidate malaria vaccines FP9 and modified vaccinia virus Ankara encoding the pre-erythrocytic antigen ME-TRAP in 1-6 year old children in a malaria endemic area

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.026

7 January 2021

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.026

7 January 2021

Safety and immunogenicity of recombinant poxvirus HIV-1 vaccines in young adults on highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.026

7 January 2021

A cytoplasmic RNA vector derived from nontransmissible Sendai virus with efficient gene transfer and expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.026

7 January 2021

A novel DNA vaccine based on ubiquitin-proteasome pathway targeting 'self'-antigens expressed in melanoma/melanocyte

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.026

7 January 2021

The ubiquitin–proteasome system plays essential roles in presenting an 8-mer CTL epitope expressed in APC to corresponding CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.026

7 January 2021

The involvement of immunoproteasomes in induction of MHC class I-restricted immunity targeting Toxoplasma SAG1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.026

7 January 2021

An improved method for recovery of F-defective Sendai virus expressing foreign genes from cloned cDNA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.026

7 January 2021

Ubiquitin-fusion degradation pathway plays an indispensable role in naked DNA vaccination with a chimeric gene encoding a syngeneic cytotoxic T lymphocyte epitope of melanocyte and green fluorescent protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.026

7 January 2021

Long-term protective immunity induced against Trypanosoma cruzi infection after vaccination with recombinant adenoviruses encoding amastigote surface protein-2 and trans-sialidase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.026

7 January 2021

CD8+-T-cell-dependent control of Trypanosoma cruzi infection in a highly susceptible mouse strain after immunization with recombinant proteins based on amastigote surface protein 2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.026

7 January 2021

Functional significance of the perforin/granzyme cell death pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.026

7 January 2021

Ex vivo identification, isolation and analysis of tumor-cytolytic T cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.026

7 January 2021

Heterologous prime/boost immunization of rhesus monkeys by using diverse poxvirus vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.026

7 January 2021

Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.026

7 January 2021

Prime-boost vaccination with a fowlpox vector and an inactivated avian influenza vaccine is highly immunogenic in Pekin ducks challenged with Asian H5N1 HPAI.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.026

7 January 2021

Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.026

7 January 2021

Development of immunostimulatory virotherapy using non-transmissible Sendai virus-activated dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.026

7 January 2021

Efficient gene transfer to airway epithelium using recombinant Sendai virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.026

7 January 2021

Toll-like receptor 3 promotes cross-priming to virus-infected cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.026

7 January 2021

The Genome Sequence of Trypanosoma cruzi, Etiologic Agent of Chagas Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.026

7 January 2021

CD8+ T-Cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.026

7 January 2021

Distinct kinetics of effector CD8+ cytotoxic T cells after infection with Trypanosoma cruzi in naive or vaccinated mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.026

7 January 2021

Modulation of CD4(+) T cell-dependent specific cytotoxic CD8(+) T cells differentiation and proliferation by the timing of increase in the pathogen load

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.026

7 January 2021

Infection with Trypanosoma cruzi restricts the repertoire of parasite-specific CD8+ T cells leading to immunodominance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.026

7 January 2021

Vaccination with trypomastigote surface antigen 1-encoding plasmid DNA confers protection against lethal Trypanosoma cruzi infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.026

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2009.08.026

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43591184&oldid=2101737514"